Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.750
-0.020 (-0.53%)
At close: Dec 5, 2025, 4:00 PM EST
3.790
+0.040 (1.07%)
After-hours: Dec 5, 2025, 5:52 PM EST
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $41.94 million as of December 5, 2025. Its market cap has increased by 26.27% in one year.
Market Cap
41.94M
Enterprise Value
29.67M
1-Year Change
26.27%
Ranking
Category
Stock Price
$3.75
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $41.94M, an increase of 38.29%. That is a compound annual growth rate of 6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 41.94M | 21.91% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 909.09B |
| Johnson & Johnson | 487.71B |
| AbbVie | 403.12B |
| UnitedHealth Group | 298.89B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 251.23B |
| Abbott Laboratories | 216.72B |